- Home
- PMEC vs CCEL Comparison
PMEC vs CCEL Comparison
Compare PMEC & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- CCEL
- Stock Information
- Founded
- PMEC 1984
- CCEL 1989
- Country
- PMEC Singapore
- CCEL United States
- Employees
- PMEC N/A
- CCEL N/A
- Industry
- PMEC
- CCEL Managed Health Care
- Sector
- PMEC
- CCEL Health Care
- Exchange
- PMEC Nasdaq
- CCEL Nasdaq
- Market Cap
- PMEC 46.1M
- CCEL 51.9M
- IPO Year
- PMEC 2023
- CCEL 1997
- Fundamental
- Price
- PMEC $1.18
- CCEL $5.19
- Analyst Decision
- PMEC
- CCEL Strong Buy
- Analyst Count
- PMEC 0
- CCEL 1
- Target Price
- PMEC N/A
- CCEL $8.50
- AVG Volume (30 Days)
- PMEC 61.7K
- CCEL 10.3K
- Earning Date
- PMEC 12-31-2024
- CCEL 07-14-2025
- Dividend Yield
- PMEC N/A
- CCEL 7.86%
- EPS Growth
- PMEC N/A
- CCEL N/A
- EPS
- PMEC N/A
- CCEL 0.01
- Revenue
- PMEC $74,310,000.00
- CCEL $32,102,750.00
- Revenue This Year
- PMEC N/A
- CCEL $2.49
- Revenue Next Year
- PMEC N/A
- CCEL $0.95
- P/E Ratio
- PMEC N/A
- CCEL $563.74
- Revenue Growth
- PMEC 3.94
- CCEL 2.33
- 52 Week Low
- PMEC $0.49
- CCEL $4.75
- 52 Week High
- PMEC $1.40
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- PMEC 51.43
- CCEL 52.22
- Support Level
- PMEC $1.12
- CCEL $4.80
- Resistance Level
- PMEC $1.25
- CCEL $5.15
- Average True Range (ATR)
- PMEC 0.10
- CCEL 0.20
- MACD
- PMEC -0.01
- CCEL 0.05
- Stochastic Oscillator
- PMEC 37.14
- CCEL 75.86
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.